Verition Fund Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-380,182
Closed -$69.8M 2243
2021
Q2
$69.8M Buy
380,182
+228,374
+150% +$42M 0.64% 17
2021
Q1
$23.2M Buy
151,808
+1,707
+1% +$261K 0.26% 30
2020
Q4
$23.5M Buy
150,101
+140,456
+1,456% +$21.9M 0.21% 45
2020
Q3
$1.1M Sell
9,645
-1,742
-15% -$199K 0.02% 292
2020
Q2
$1.28M Buy
+11,387
New +$1.28M 0.04% 282
2020
Q1
Sell
-9,131
Closed -$988K 1061
2019
Q4
$988K Sell
9,131
-136
-1% -$14.7K 0.02% 369
2019
Q3
$908K Sell
9,267
-11,967
-56% -$1.17M 0.03% 348
2019
Q2
$2.78M Buy
21,234
+8,560
+68% +$1.12M 0.08% 138
2019
Q1
$1.71M Sell
12,674
-5,843
-32% -$790K 0.07% 223
2018
Q4
$1.8M Buy
18,517
+16,362
+759% +$1.59M 0.13% 130
2018
Q3
$300K Sell
2,155
-945
-30% -$132K 0.01% 965
2018
Q2
$385K Buy
3,100
+919
+42% +$114K 0.02% 719
2018
Q1
$243K Buy
+2,181
New +$243K 0.02% 871
2017
Q4
Sell
-3,835
Closed -$538K 1269
2017
Q3
$538K Buy
+3,835
New +$538K 0.04% 488
2017
Q2
Sell
-1,757
Closed -$213K 1317
2017
Q1
$213K Buy
+1,757
New +$213K 0.02% 949
2016
Q4
Sell
-3,240
Closed -$397K 1382
2016
Q3
$397K Sell
3,240
-5,005
-61% -$613K 0.04% 540
2016
Q2
$963K Buy
+8,245
New +$963K 0.12% 157
2015
Q2
Sell
-1,633
Closed -$283K 727
2015
Q1
$283K Buy
+1,633
New +$283K 0.03% 197
2014
Q3
Sell
-2,830
Closed -$442K 879
2014
Q2
$442K Buy
2,830
+1,288
+84% +$201K 0.05% 256
2014
Q1
$235K Buy
+1,542
New +$235K 0.04% 314
2013
Q4
Sell
-3,229
Closed -$375K 675
2013
Q3
$375K Buy
3,229
+823
+34% +$95.6K 0.06% 233
2013
Q2
$222K Buy
+2,406
New +$222K 0.04% 432